Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: CT Antigen TCR-redirected T Cells for Ovarian Cancer. [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating TCR-redirected T cells targeting CT antigen for ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer [Phase 2]
Phase 2 clinical trial of Kevetrin in ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Sentinel Node Detection in Clinical Early Stage Ovarian Cancer [NA]
Completed clinical trial investigating sentinel node detection in early-stage ovarian cancer with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial update for BIBF 1120 in bevacizumab-resistant, persistent, or recurrent epithelial ovarian cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors [Phase 2]
Phase 2 clinical trial update of durvalumab (MEDI4736) in patients with brain metastases from epithelial-derived tumors, with terminated sta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial update evaluating ixabepilone in relapsed/refractory advanced ovarian epithelial or primary peritoneal cancer has c…
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer [Phase 2]
Phase II study evaluating NGR-hTNF in combination with doxorubicin for platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer [Phase 2]
Phase 2 trial evaluating NGR-hTNF in combination with doxorubicin for advanced or metastatic ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer [Phase 3]
Phase 3 trial examining secondary debulking surgery with or without hyperthermic intraperitoneal chemotherapy for stage III ovarian cancer h…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
Clinical trial update reporting outcomes on health-related quality of life and symptoms for patients recovering from major gynecologic cance…
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma [Phase 2]
Phase II study of DCVAC/OvCa with carboplatin and gemcitabine in relapsed platinum-sensitive epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and pemetrexed in recurrent platinum-sensitive ovarian cancer completed.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer [Phase 2]
Phase 2 trial evaluating a regimen of carboplatin, etoposide, cyclophosphamide, and autologous bone marrow transplant in relapsed or refract…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial update investigating standard of care therapy with involved field radiation therapy for selective recurrent ovarian c…
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) [Phase 3]
Phase 3 trial (ARIEL3) evaluating rucaparib as switch maintenance after platinum in relapsed high-grade serous or endometrioid ovarian cance…
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial update evaluating upfront chemotherapy with bevacizumab in advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients [Phase 1]
Phase 1 study evaluating docetaxel in combination with PTK787 in metastatic breast cancer and gynecologic cancers; the trial conducted by Da…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
This clinical trial update summarizes completed findings on fertility issues and sexual function in young women diagnosed with early-stage o…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma [Phase 2]
A Phase 2 clinical trial update for sunitinib in patients with recurrent ovarian clear cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors [Phase 1]
Phase 1 study of nintedanib plus bevacizumab in advanced solid tumors has completed, assessing safety and preliminary activity across severa…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer [Phase 2]
A Phase 2 trial of CRLX101 in combination with Bevacizumab for recurrent ovarian, fallopian tube, or primary peritoneal cancer has completed…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) [Phase 1, Phase 2]
A Phase 1/2 trial of pembrolizumab plus chemotherapy in patients with various advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy [Phase 1]
This Phase 1 study of veliparib in patients with malignant solid tumors that did not respond to prior therapy has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy [Phase 2]
A Phase 2 trial assessing the safety and efficacy of Quisinostat in combination with chemotherapy for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of DMUC4064A in platinum-resistant ovarian cancer and unresectable pancreatic cance…